Name | LY300503 |
---|
Description | LY300503 is an enantiomer of LY191704. LY191704 is a human type I 5α-reductase inhibitor[1][2]. |
---|---|
Related Catalog | |
In Vivo | LY300503 (30-300 mg/kg; p.o. for 14 d) exhibits the mean dose-normalized AUC value of 56% after the first dose and 38% after the last dose in rats[2]. |
References |
Molecular Formula | C14H16ClNO |
---|---|
Molecular Weight | 249.74 |